...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Genomic and Molecular Characterization of Clinical Isolates of Enterobacteriaceae Harboring mcr-1 in Colombia, 2002 to 2016
【24h】

Genomic and Molecular Characterization of Clinical Isolates of Enterobacteriaceae Harboring mcr-1 in Colombia, 2002 to 2016

机译:肠杆菌植物植物临床分离物的基因组和分子表征MCR-1在哥伦比亚,2002至2016年

获取原文
获取原文并翻译 | 示例
           

摘要

Polymyxins are last-resort antimicrobial agents used to treat infections caused by carbapenem-resistant Enterobacteriaceae. Due to the worldwide dissemination of polymyxin resistance in animal and human isolates, we aimed to characterize polymyxin resistance associated with the presence of mcr-1 in Enterobacteriaceae and nonfermenter Gram-negative bacilli, using isolates collected retrospectively in Colombia from 2002 to 2016. A total of 5,887 Gram-negative clinical isolates were studied, and 513 were found to be resistant to the polymyxins. Susceptibility to colistin was confirmed by broth microdilution for all mcr-1-positive isolates, and these were further subjected to whole-genome sequencing (WGS). The localization of mcr-1 was confirmed by S1 pulsed-field gel electrophoresis (S1-PFGE) and CeuI-PFGE hybridization. Transferability was evaluated by mating assays. A total of 12 colistin-resistant isolates recovered after 2013 harbored mcr-1, including 8 Escherichia coli, 3 Salmonella enterica serovar Typhimurium, and 1 Klebsiella pneumoniae isolate. E. coli isolates were unrelated by PFGE and belonged to 7 different sequence types (STs) and phylogroups. S. Typhimurium and K. pneumoniae isolates belonged to ST34 and ST307, respectively. The mcr-1 gene was plasmid borne in all isolates but two E. coli isolates which harbored it on the chromosome. Conjugation of mcr-1 was successful in 8 of 10 isolates (8.2 x 10(-5) to 2.07 x 10(-1) cell per recipient). Plasmid sequences showed that the mcr-1 plasmids belonged to four different Inc groups (a new IncP-1 variant and the IncFII, IncHI1, and IncH families). Our results indicate that mcr-1 is circulating in clinical isolates of colistin-resistant Enterobacteriaceae in Colombia and is mainly harbored in transferable plasmids.
机译:多元辛是用于治疗Carbapenem抗生素痤疮造成的感染的最后一段抗菌剂。由于全球传播动物和人类分离物中的多脂素抗性,我们的目的是在2002年至2016年的哥伦比亚中回顾性收集的分离物,表征了与肠杆菌和革兰氏阴性的存在相关的多辛含量抗性相关。研究了5,887克阴性临床分离株,发现513个耐多酸辛。通过对所有MCR-1阳性分离株的肉汤微脱液确认对Colistin的易感性,并进一步进行全基因组测序(WGS)。通过S1脉冲场凝胶电泳(S1-PFGE)和Ceui-PFGE杂交来证实MCR-1的定位。通过配合测定评估可转移性。在2013年后,共回收了12个耐菌抗性分离物,其中包括8个大肠杆菌,3种大肠杆菌,3个沙门氏菌肠道毒素伤寒毒蕈,和1个Klebsiella肺炎肠道分离物。大肠杆菌分离株通过PFGE不相关,属于7种不同的序列类型(STS)和晶粒。 S. Typhimurium和K.肺炎群岛分别属于ST34和ST307。 MCR-1基因在所有分离株中载有质粒,但两种大肠杆菌分离物在染色体上覆盖。 MCR-1的缀合在10个分离物中的8个(8.2×10(-5)至2.07×10(-1)细胞中成功)。质粒序列表明,MCR-1质粒属于四种不同的Inc基团(新的INCP-1变体和INCFII,INCFII,英寸家族)。我们的结果表明,MCR-1在哥伦比亚耐药肠杆菌菌的临床分离株中循环,主要是在可转移质粒中呈现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号